Home R&D Drug Delivery

Drug Delivery

Metal-Organic Frameworks (MOFs) as drug delivery systems

Subcutaneous therapy for chronic inflammatory demyelinating polyneuropathy

Green light to gemtuzumab ozogamicin for acute myeloid leukemia

Gene therapy for transfusion-dependent β-thalassemia

New vaccine to protect adolescent and adult from Men B

Exceptional curcumstances approval for dinutuximab beta in neuroblastoma

New combo empagliflozin and linagliptin in type 2 diabetes

Palbociclib to treat breast cancer

Somatic cell therapy product for leukaemias and lymphomas

Eluxadoline for the treatment of irritable bowel syndrome with diarrhoea

1234Page 1 of 4
© © 2024 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151